Articles

A-127 REVERSAL OF A DABIGATRAN OVERLOAD WITH IDARUCIZUMAB: 5 MG MAY BE A VERY INSUFFICIENT DOSE

BJH - volume 9, issue Abstract Book BSTH, february 2018

P. Cauchie , T. Kimbimbi , J. Van Ryn , M. Piagnerelli

Read more

A-121 PERFORMANCES EVALUATION OF A NEW PT REAGENT STA® – NEOPTIMAL FOR PT/INR MEASUREMENT AND EXOGENOUS COAGULATION FACTOR ASSAYS

BJH - volume 9, issue Abstract Book BSTH, february 2018

R. Cupaiolo , M. Blauwaert , J. Yernaux , D. Govaerts , P. Cauchie

Read more

A-118 PERFORMANCES EVALUATION OF A NEW COAGULATION ANALYSER, STA R MAX® 2

BJH - volume 9, issue Abstract Book BSTH, february 2018

R. Cupaiolo , I. Courtois , E. Saccomando , D. Govaerts , P. Cauchie

Read more

A-119 A PATIENT WITH A TYPE 2 CB VON WILLEBRAND DISEASE: LABORATORY DIAGNOSIS AND RESPONSE TO DESMOPRESSIN

BJH - volume 9, issue Abstract Book BSTH, february 2018

R. Cupaiolo , A. Athanasopoulos , V. Farinella , D. Govaerts , P. Cauchie

Read more

Validation of a ready to use Clauss fibrinogen

BJH - 2014, issue Abstract Book BSTH, november 2014

D. Fage , I. Courtois , E. Fosse , E. Saccomando , P. Cauchie

Read more

P.47 Impact of the oral and direct Factor Xa inhibitor Rivaroxaban on five routine coagulation assays, an in-vitro and ex-vivo study

BJH - 2013, issue BHS Abstractbook, january 2013

L. Dierge PharmD, E. Fosse , A. Alewaeters , D. Govaerts , P. Cauchie

Read more